Jonassen, Rune
Harmer, Catherine J.
Hilland, Eva
Maglanoc, Luigi A.
Kraft, Brage
Browning, Michael
Stiles, Tore C.
Haaland, Vegard Ø.
Berge, Torkil
Landrø, Nils Inge
Funding for this research was provided by:
Norges Forskningsråd (229135)
The South East Norway Health Authority Research Funding (2015052)
Medical Research Foundation (MR/N008103/3)
Article History
Received: 13 July 2018
Accepted: 8 April 2019
First Online: 8 May 2019
Ethics approval and consent to participate
: Written informed consent was obtained before enrollment. The study was approved by The Regional Ethical Committee for Medical and Health Research for Southern Norway (2014/217/REK Sør-Øst D). The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
: Not applicable.
: CJH has received consultancy fees form Johnson and Johnson Inc., P1 vital and Lundbeck. MB is employed part time by P1 vital Ltd. and owns shares in P1 vital products Ltd. He has received travel expenses from Lundbeck for attending conferences. NIL has received consultancy fees and travel expenses from Lundbeck. All other authors state no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.